Many hormonal treatments to choose from for endometriosis

&NA;
In: Drugs & Therapy Perspectives · 2000 · vol. 16(3) , pp. 5–8 · doi:10.2165/00042310-200016030-00002 · W4250873554
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-13 ⓘ

This article reviews multiple hormonal treatment options available for endometriosis, discussing their efficacy and applications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text ⓘ

This article provides an overview of many hormonal treatments available for endometriosis, drawing on published guidance and comparative studies of drug classes. It synthesizes evidence referenced in sources such as recommendations for current drug therapy, long-term follow-up of gonadotrophin-releasing hormone analogues, and randomized comparisons like gestrinone versus a gonadotrophin-releasing hormone agonist, but the excerpt does not include original data or new experimental results. A key caveat is that it is a narrative, reference-based perspective rather than a systematic review using the full set of trials. This paper is centrally about endometriosis — it discusses the range of hormonal medical treatments for the condition based on prior literature.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,247 characters · extracted from oa-doi-fallback · click to expand
References Emovon E, Wardle P, Cahill D. Guide to the medical treatment of endometriosis. Prescriber 1999 Nov; 5: 54–60 Bergqvist A. Current drug therapy: recommendations for the treatment of endometriosis. Drugs 1999 Jul; 58(1); 39–50 Waller KG, Shaw RW. Gonadotrophin-releasing hormone analogues for the treatment of endometriosis: long term follow-up. Fertil Steril 1993 59: 511–4 British National Formulary No. 39. London: The Pharmaceutical Press, 2000 Mar Venturini PL, Fasce V, Gorlero F, et al. Chronic pelvic pain: oral contraceptives and non-steroidal anti-inflammatory compounds. Cephalalgia 1997; 17 Suppl. 20: 29–31 Gestrinone Italian Study Group. Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Fertil Steril 1996; 66: 911–9 Hull ME, Barbieri RL. Nafarelin in the treatment of endometriosis. Gynecol Obstet Invest 1994; 37: 263–4 Rights and permissions About this article Cite this article Many hormonal treatments to choose from for endometriosis. Drugs Ther. Perspect 16, 5–8 (2000). https://doi.org/10.2165/00042310-200016030-00002 Published: Issue date: DOI: https://doi.org/10.2165/00042310-200016030-00002

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK